Skip to content

botulinum in childhood strabismus

Botulinum Neurotoxin as first line therapy in the management of Childhood esotropia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201508001241218
Enrollment
250
Registered
2015-08-17
Start date
2015-02-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases Surgery Paediatrics childhood strabismus

Interventions

recession surgery to medial recti, both eyes

Sponsors

St John Foundation
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Children between the ages of 6 months to 6 years with essential esotropia. Children with partially accommodative esotropia who require surgery to correct residual angle. Children diagnosed with acquired non accommodative esotropia. Children with concomitant esotropia secondary to neurodevelopmental disorders.

Exclusion criteria

Exclusion criteria: Any concomitant esotropia corrected fully with spectacle correction. Significant associated vertical misalignment such as dissociative vertical deviation or inferior oblique overaction requiring surgery for these conditions. Strabismus secondary to ocular pathology. incomitant esotropia. Patients refusing to be randomised.

Design outcomes

Primary

MeasureTime frame
degree of alignment;Adverse events;cost effectiveness comparison

Countries

South Africa

Contacts

Public ContactAdelaide Molepane

assistant

cockinos@afrisys.co.za027119338783

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026